Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL588532

CC(C)C(N)C(N)c1nc(N2CCN(c3ccc(Cl)cc3)CC2)nc2c1SCC2.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ TSHR P16473 1/20 0.35
▸ C1S P09871 2/20 0.34
▸ DPP4 P27487 1/20 0.34
▸ DPP7 Q9UHL4 1/20 0.34
▸ MAPT P10636 4/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ CETP P11597 3/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CCR1 P32246 1/20 0.33
▸ GPR6 P46095 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ AKR1C3 P42330 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL2672412 0.82 GPR6 (0.36) KMT2AMEN1TSHRMAPTSMN1; SMN2
Trifluoroacetic Acid SCHEMBL590103 0.81 MEN1 (0.37) KMT2AMEN1HTTC1SDPP4
SCHEMBL4152368 0.77 CETP (0.40) KMT2ATSHRMAPTSMN1; SMN2CETP
SCHEMBL588533 0.76 SMN1; SMN2 (0.36) KMT2AMEN1HTTTSHRDPP4
SCHEMBL588747 0.75 CCR1 (0.39) KMT2ATSHRMAPTSMN1; SMN2CYP3A4
SCHEMBL588746 0.75 CCR1 (0.39) KMT2ATSHRMAPTSMN1; SMN2CYP3A4
SCHEMBL588576 0.71 KMT2A (0.43) KMT2AMEN1TSHRMAPTSMN1; SMN2
SCHEMBL2922890 0.71 ALDH1A1 (0.48) KMT2ATSHRMAPTSMN1; SMN2CETP
SCHEMBL588859 0.71 ALDH1A1 (0.44) KMT2ATSHRMAPTSMN1; SMN2CETP
SCHEMBL4071055 0.71 CETP (0.36) KMT2ATSHRMAPTSMN1; SMN2CETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8114878-B2 6,7-dihydrothieno[3,2-d]pyrimidine for the treatment of inflammatory diseases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-02-14 — — US disclosed
Send feedback